Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-b]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones
暂无分享,去创建一个
G. Nițulescu | C. Draghici | O. Olaru | F. Dumitrascu | Sergiu Shova | L. Brasoveanu | M. Mihaila | C. Hotnog | B. Ivan | A. Anghel | Robert Ancuceanu | Stefania-Felicia Barbuceanu
[1] Ş. Direkel,et al. Synthesis, Spectroscopic Characterization, Antibacterial Activity, and Computational Studies of Novel Pyridazinone Derivatives , 2023, Molecules.
[2] Pragati Silakari,et al. Pyridazinones: A versatile scaffold in the development of potential target based novel anticancer agents , 2022, Journal of Heterocyclic Chemistry.
[3] G. Nițulescu,et al. New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation , 2022, International journal of molecular sciences.
[4] Ibrahim A. Naguib,et al. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors , 2022, Molecules.
[5] S. Saha,et al. The enthralling effect of Packing on the light emission of pyridazinone based luminophore: Crystallographic, electronic absorption and computational studies. , 2022, Journal of Molecular Structure.
[6] A. Khlebnikov,et al. Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity , 2022, Molecules.
[7] K. Shyamsunder,et al. Therapeutic potential of pyrrole and pyrrolidine analogs: an update , 2022, Molecular Diversity.
[8] S Kumar,et al. Alternative Animal Models in Predictive Toxicology. , 2021, Toxicology.
[9] G. Nițulescu,et al. Synthesis and Toxicity Evaluation of New Pyrroles Obtained by the Reaction of Activated Alkynes with 1-Methyl-3-(cyanomethyl)benzimidazolium Bromide , 2021, Molecules.
[10] V. Nenajdenko,et al. Copper‐Mediated Oxidative [3+2]‐Annulation of Nitroalkenes and Ylides of 1,2‐Diazines: Assembly of Functionalized Pyrrolo[1,2‐b]pyridazines , 2021, ChemistrySelect.
[11] Hossein Mousavi. A concise and focused overview upon arylglyoxal monohydrates-based one-pot multi-component synthesis of fascinating potentially biologically active pyridazines , 2021, Journal of Molecular Structure.
[12] M. Bostan,et al. Anticancer Activity of Some Ruthenium(III) Complexes with Quinolone Antibiotics: In Vitro Cytotoxicity, Cell Cycle Modulation, and Apoptosis-Inducing Properties in LoVo Colon Cancer Cell Line , 2021, Applied Sciences.
[13] Yi Chen,et al. Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors. , 2020, Bioorganic & medicinal chemistry letters.
[14] G. Nițulescu,et al. Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies , 2020, Molecules.
[15] Wen-en Zhao,et al. Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules. , 2020, European journal of medicinal chemistry.
[16] G. Nițulescu,et al. New heteroleptic lanthanide complexes as multimodal drugs: Cytotoxicity studies, apoptosis, cell cycle analysis, DNA interactions, and protein binding , 2020 .
[17] V. Spanò,et al. Bioactive pyrrole-based compounds with target selectivity , 2020, European Journal of Medicinal Chemistry.
[18] Kohske Takahashi,et al. Create Elegant Data Visualisations Using the Grammar of Graphics [R package ggplot2 version 3.3.2] , 2020 .
[19] George Mihai Nitulescu,et al. Artificial Intelligence Algorithms for Discovering New Active Compounds Targeting TRPA1 Pain Receptors , 2020, AI.
[20] H. Reissig,et al. The Huisgen Reaction: Milestones of the 1,3‐Dipolar Cycloaddition , 2020, Angewandte Chemie.
[21] P. Rijo,et al. Artemia species: An important tool to screen general toxicity samples. , 2020, Current pharmaceutical design.
[22] David J. Sherman,et al. Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease , 2020, Molecules.
[23] I. Mangalagiu,et al. Microwave Assisted Reactions of Fluorescent Pyrrolodiazine Building Blocks , 2019, Molecules.
[24] Suat Sarı,et al. A new series of pyndazinone derivatives as chohnesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies , 2019, Pharmacological reports : PR.
[25] A. Botezatu,et al. Modulation of the interplay between p53, ICAM-1 and VEGF in drug-treated LoVo colon cancer cells , 2019, Romanian Biotechnological Letters.
[26] A. T. Plieva. Methods for the synthesis of pyrrolo[1,2-b]pyridazine and pyrrolo[1,2-b]cinnoline derivatives (microreview) , 2019, Chemistry of Heterocyclic Compounds.
[27] Michael A. Galella,et al. Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. , 2019, ACS medicinal chemistry letters.
[28] R. Danac,et al. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives , 2019, Journal of enzyme inhibition and medicinal chemistry.
[29] D. Lüdecke. Sjplot - Data Visualization For Statistics In Social Science. , 2018 .
[30] M. Badea,et al. Cytotoxicity studies, DNA interaction and protein binding of new Al (III), Ga (III) and In (III) complexes with 5-hydroxyflavone , 2018, Applied Organometallic Chemistry.
[31] Saleh A. Ahmed,et al. Photochromism of Dihydroindolizines. Part XXI: Multiaddressable Photochromic Performances based on Pyrrolo[1,2-b]pyridazine photochromes: Kinetics, Substituent Effect and Solvatochromism , 2017 .
[32] K. McIntyre,et al. Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. , 2017, Bioorganic & medicinal chemistry letters.
[33] Manuel Koller,et al. robustlmm : An R Package for Robust Estimation of Linear Mixed-Effects Models , 2016 .
[34] Florent Baty,et al. Dose-Response Analysis Using R , 2015, PloS one.
[35] C. Draghici,et al. Coumarin substituted pyrrolo-fused heterocyclic systems by 1,3-dipolar cycloadditon reactions , 2015, Monatshefte für Chemie - Chemical Monthly.
[36] S. Dubey,et al. Pyridazinone: an important element of pharmacophore possessing broad spectrum of activity , 2015, Medicinal Chemistry Research.
[37] G. Gribble,et al. Total synthesis of atorvastatin via a late-stage, regioselective 1,3-dipolar münchnone cycloaddition , 2015 .
[38] G. Sheldrick. SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.
[39] G. Sheldrick. Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.
[40] David S. Nirschl,et al. Discovery of pyrrolo[1,2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors. , 2014, Bioorganic & medicinal chemistry letters.
[41] H. Reissig,et al. Münchnones--new facets after 50 years. , 2014, Angewandte Chemie.
[42] D. Bates,et al. Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.
[43] A. Gomtsyan,et al. Heterocycles in drugs and drug discovery , 2012, Chemistry of Heterocyclic Compounds.
[44] H. Kohno,et al. Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF₁) receptor antagonists. , 2012, Bioorganic & medicinal chemistry.
[45] William N. Venables,et al. Modern Applied Statistics with S , 2010 .
[46] Sanford Weisberg,et al. An R Companion to Applied Regression , 2010 .
[47] C. Draghici,et al. New Pyrrolo[1,2‐b]pyridazine Derivatives. , 2010 .
[48] Masahiro Tanaka,et al. Discovery of pyrrolopyridazines as novel DGAT1 inhibitors. , 2010, Bioorganic & medicinal chemistry letters.
[49] Richard J. Gildea,et al. OLEX2: a complete structure solution, refinement and analysis program , 2009 .
[50] I. Mangalagiu,et al. New pyridazine derivatives: synthesis, chemistry and biological activity. , 2009, Bioorganic & medicinal chemistry.
[51] F. Dumitrascu,et al. Pyrrolo[1,2-b]pyridazines. A revisit , 2008 .
[52] M. Caira,et al. A Novel Approach for the Synthesis of Highly Fluorescent Pyrrolo[1,2-b]pyridazines , 2008 .
[53] T. Rantala,et al. Optical spectroscopic characteristics and TD-DFT calculations of new pyrrolo[1,2-b]pyridazine derivatives , 2008 .
[54] Edsel A. Peña,et al. Global Validation of Linear Model Assumptions , 2006, Journal of the American Statistical Association.
[55] M. Poss,et al. Pyrrolopyridazine MEK inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[56] S. Sánchez-Fortún,et al. Effects of selected biocides used in the disinfection of cooling towers on toxicity and bioaccumulation in Artemia larvae , 2005, Environmental toxicology and chemistry.
[57] R. Huisgen,et al. A New Type of Mesoionic Aromatic Compound and Its 1,3‐Dipolar Cycloaddition Reactions with Acetylene Derivatives , 1964 .
[58] J. King,et al. The Preparation of Some Pyridazonyl Acids , 1952 .
[59] J. R.,et al. Chemistry , 1929, Nature.
[60] Ranjeet Kumar,et al. Development of robust folded scaffold as fluorescent materials using butylidine linked pyridazinone based systems via aromatic π∙∙∙π Stacking Interactions , 2022, New Journal of Chemistry.
[61] W. Ollis,et al. Meso-ionic compounds , 2022, Advances in Heterocyclic Chemistry.
[62] M. Caira,et al. Pyrroloquinolines, imidazoquinolines, and pyrroloquinazolines with a bridgehead nitrogen , 2019, Advances in Heterocyclic Chemistry.
[63] Tony Y. Zhang. The Evolving Landscape of Heterocycles in Drugs and Drug Candidates , 2017 .
[64] O. Olaru,et al. CHEMICAL , ANTIOXIDANT AND TOXICITY EVALUATION OF ROSEMARY LEAVES AND ITS DRY EXTRACT , 2017 .
[65] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[66] M. Ferdeș,et al. REAL-TIME ANALYSIS OF QUERCETIN, RESVERATROL AND /OR DOXORUBICIN EFFECTS IN MCF-7 CELLS , 2013 .
[67] O. Olaru,et al. PRELIMINARY RESEARCH ON PORTULACA GRANDIFLORA HOOK. SPECIES (PORTULACACEAE) FOR THERAPEUTIC USE , 2013 .
[68] A. Botezatu,et al. GENISTEIN POTENTIATES THE APOPTOTIC EFFECT OF 5-FLUOROURACYL IN COLON CANCER CELL LINES , 2013 .
[69] Yong-Jin Wu. Chapter 1 - Heterocycles and Medicine: A Survey of the Heterocyclic Drugs Approved by the U.S. FDA from 2000 to Present , 2012 .
[70] C. Davila,et al. CONTRIBUTIONS TO THE STUDY OF SOME SPECIES IN THE PORTULACA (PORTULACACEAE) GENUS. PRELIMINARY BOTANICAL AND PHYTOBIOLOGICAL RESEARCH ON PORTULACA OLERACEAE L AND PORTULACA GRADIFLORA HOOKER SPECIES , 2011 .
[71] Brian D. Ripley,et al. Modern applied statistics with S, 4th Edition , 2002, Statistics and computing.
[72] C. A. Ramsden,et al. Meso-ionic heterocycles (1976–1980) , 1982 .
[73] D. E. Kuhla,et al. Pyrrolodiazines with a Bridgehead Nitrogen , 1977 .
[74] J. King,et al. Hydrazides of Some Pyridazonyl Substituted Acids , 1956 .